Shadi Tabibian: Molecular Diagnosis of Inherited Platelet Disorders
Shadi Tabibian, Director of the Iranian Comprehensive Hemophilia Care Center (ICHC) and Deputy of research at Blood Diseases Research Centers, Iran University of Medical Sciences, shared a post on LinkedIn:
“Proud to share our newly published narrative review in Thrombosis Journal (2025):
Title: Molecular diagnosis of inherited platelet disorders: a tale of two realities – advanced vs. resource-limited setting
Authors: Seyed Mehrab Safdari, Sina Jozdani, Mahsa Mottaghizadeh-Jazi, Maryam Shayanmanesh, Alireza Khanahmad, Mehdi Bakhtiyaridovvombaygi, Azadeh Rezazadeh and Shadi Tabibian

In this review, we discuss how molecular technologies—particularly next-generation sequencing (NGS)—are transforming the diagnosis of inherited platelet disorders, while also emphasizing why phenotypic and laboratory investigations (platelet function testing, flow cytometry, immunofluorescence, and electron microscopy) remain essential for first-line evaluation.
We also highlight a critical global challenge: in resource-limited settings, restricted access to genetic platforms (cost, infrastructure, and expertise) can delay or prevent accurate diagnosis—ultimately affecting patient care.
Key takeaways:
• NGS improves diagnostic precision and supports tailored management
• Conventional laboratory pathways remain foundational for initial diagnosis
• Closing the diagnostic gap requires affordable testing models, collaboration, and capacity building
I’d be honored if you read the paper and share your thoughts or experience from your own setting.”

Stay updated with Hemostasis Today.
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026